Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions

v3.21.1
Related Party Transactions
3 Months Ended
Mar. 31, 2021
Related Party Transactions [Abstract]  
Related Party Transactions Related Party TransactionsDuring the three months ended March 31, 2021 and 2020, our joint venture in China, owned 80 percent by us and 20 percent by a wholly owned subsidiary of Fosun Pharma, did not borrow any amounts from the Company or our joint venture partner. As of March 31, 2021 and December 31, 2020 our joint venture in China held a note payable to the Company of $4.9 million and $4.8 million, respectively. As of March 31, 2021 and December 31, 2020 our joint venture held a note payable to our joint venture partner of $1.2 million and $1.2 million, respectively. These notes are payable in less than one year and bear interest of 3.0 percent. The note between the joint venture and the Company eliminates in consolidation.